The expression of ERβ is decreased in breast cancer cells compared to the high levels of the receptor found in healthy breast tissue 40, 43, 44, and its downregulation is common in tumors and correlated with malignancy 43, 44, 45, 46, 47. The gene discussed is ESR2; the disease is breast carcinoma.